Testing effectiveness (Phase 2)Active Not RecruitingNCT07223632
What this trial is testing
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
Who this might be right for
Charcot Marie Tooth Disease (CMT)Neuromuscular Diseases (NMD)
Vanda Pharmaceuticals 1